Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
The Lancet. Infectious Diseases|February 20, 2018
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trialMical Paul, George L Daikos, Emanuele Durante-Mangoni, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistanceSammy Frenk, Elizabeth Temkin, Mor N Lurie-Weinberger, et al.
BMC Infectious Diseases|April 1, 2021
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validityVered Daitch, Mical Paul, George L Daikos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2024
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)María Paniagua-García, Jose M Bravo-Ferrer, Salvador Pérez-Galera, et al.
Eclinicalmedicine|March 10, 2023
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, et al.
Pageof 11